Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · IEX Real-Time Price · USD
2.52
+0.11 (4.56%)
At close: Nov 27, 2023, 4:00 PM
2.42
-0.10 (-3.97%)
Pre-market: Nov 28, 2023, 4:15 AM EST
Werewolf Therapeutics Stock Forecast
Stock Price Forecast
According to 4 stock analysts, the average 12-month stock price forecast for HOWL stock stock is $10.58, which predicts an increase of 319.84%. The lowest target is $8.30 and the highest is $15. On average, analysts rate HOWL stock stock as a strong buy.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HOWL stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +495.24% | Nov 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +495.24% | Oct 31, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +495.24% | Sep 19, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +495.24% | Sep 15, 2023 |
Wedbush | Wedbush | Buy Initiates $9 | Buy | Initiates | $9 | +257.14% | Aug 24, 2023 |
Financial Forecast
Revenue This Year
15.95M
from 16.40M
Decreased by -2.76%
Revenue Next Year
5.10M
from 15.95M
Decreased by -68.02%
EPS This Year
-1.34
from -1.86
EPS Next Year
-1.58
from -1.34
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | 23.6M | 21.0M | 52.5M | 52.5M | 28.5M |
Avg | 15.9M | 5.1M | 18.1M | 12.8M | 8.4M |
Low | 12.3M | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | 44.0% | 31.7% | 929.4% | 190.0% | 123.2% |
Avg | -2.8% | -68.0% | 255.0% | -29.6% | -34.4% |
Low | -25.3% | - | - | - | - |
EPS Forecast
EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | -1.09 | -1.48 | -1.07 | -1.35 | -2.25 |
Avg | -1.34 | -1.58 | -1.50 | -1.32 | -2.18 |
Low | -1.47 | -1.79 | -2.37 | -1.26 | -2.10 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.